6171 - 6180 of 8137 Results
Title
Year
-
RESTRICTEDTitle: Suspected non-Alzheimer's pathology – Is it non-Alzheimer's or non-amyloid?Journal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 36Issue #:Start Page: 20End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.02.003Citation Count: 33
-
RESTRICTEDTitle: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 18End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017Citation Count: 60
- Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings2017OPENTitle: Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling SettingsJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 26Issue #: 6Start Page: 1165End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0123-6Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10897-017-0123-6Citation Count: 10
- Multiple reaction monitoring (MRM)‐profiling for biomarker discovery applied to human polycystic ovarian syndrome2017RESTRICTEDTitle: Multiple reaction monitoring (MRM)‐profiling for biomarker discovery applied to human polycystic ovarian syndromeJournal Name: Rapid Communications in Mass SpectrometryPublisher: WileyVol: 31Issue #: 17Start Page: 1462End Page: 1470Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/rcm.7927Citation Count: 35
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease2017OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 86
-
OPENTitle: Estimation of genetic risk function with covariates in the presence of missing genotypesJournal Name: Statistics in MedicinePublisher: WileyVol: 36Issue #: 22Start Page: 3533End Page: 3546Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/sim.7376Best OA location URL: https://europepmc.org/articles/pmc5583003?pdf=renderCitation Count: 4
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease2017OPENTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 18
-
OPENTitle: Latent Cognitive Phenotypes in De Novo Parkinson’s Disease: A Person-Centered ApproachJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 7Start Page: 551End Page: 563Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000406Best OA location URL: https://europepmc.org/articles/pmc6435330?pdf=renderCitation Count: 8
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease2017OPENTitle: Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-04254-yBest OA location URL: https://doi.org/10.1038/s41598-017-04254-yCitation Count: 24